rs1262366952

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004327.4(BCR):​c.214C>G​(p.Arg72Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R72W) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)

Consequence

BCR
NM_004327.4 missense

Scores

1
2
15

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.426

Publications

0 publications found
Variant links:
Genes affected
BCR (HGNC:1014): (BCR activator of RhoGEF and GTPase) A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The unregulated tyrosine kinase activity of BCR-ABL1 contributes to the immortality of leukaemic cells. The BCR protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac and other kinases. Two transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19218332).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004327.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCR
NM_004327.4
MANE Select
c.214C>Gp.Arg72Gly
missense
Exon 1 of 23NP_004318.3
BCR
NM_021574.3
c.214C>Gp.Arg72Gly
missense
Exon 1 of 22NP_067585.2P11274-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BCR
ENST00000305877.13
TSL:1 MANE Select
c.214C>Gp.Arg72Gly
missense
Exon 1 of 23ENSP00000303507.8P11274-1
BCR
ENST00000359540.7
TSL:1
c.214C>Gp.Arg72Gly
missense
Exon 1 of 22ENSP00000352535.3P11274-2
BCR
ENST00000928588.1
c.214C>Gp.Arg72Gly
missense
Exon 1 of 23ENSP00000598647.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.46
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.41
T
Eigen
Benign
-0.37
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.47
N
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.19
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.66
N
PhyloP100
0.43
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-1.7
N
REVEL
Benign
0.080
Sift
Benign
0.19
T
Sift4G
Benign
0.24
T
Polyphen
0.0050
B
Vest4
0.17
MutPred
0.60
Gain of loop (P = 0.0079)
MVP
0.39
MPC
0.94
ClinPred
0.52
D
GERP RS
3.8
Varity_R
0.31
gMVP
0.26
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1262366952; hg19: chr22-23523361; API